CN104225056A - Drug for treating rheumatic arthritis - Google Patents
Drug for treating rheumatic arthritis Download PDFInfo
- Publication number
- CN104225056A CN104225056A CN201410485218.0A CN201410485218A CN104225056A CN 104225056 A CN104225056 A CN 104225056A CN 201410485218 A CN201410485218 A CN 201410485218A CN 104225056 A CN104225056 A CN 104225056A
- Authority
- CN
- China
- Prior art keywords
- rheumatic arthritis
- radix
- medicine
- drug
- treating rheumatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention aims to provide a drug prepared by taking traditional Chinese medicine as bulk drugs and used for treating rheumatic arthritis. Clematis chinensis, angelica sinensis, radix cyathulae, pubescent angelica roots, notopterygium roots, rhizoma corydalis and prepared rehmannia roots are mixed evenly, and are smashed into 100-120 mesh medicine powder, the medicine powder is sterilized and disinfected, and a powder product is obtained. The drug replenishes the vital essence and the blood, promots blood circulation to remove blood stasis, dispells wind and eliminates dampness, pain relief is taken as the principle for treatment, the effect of treating rheumatic arthritis is good, and no side effect exists.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of rheumatic arthritis, especially relating to a kind of take Chinese medicine as the medicine for the treatment of rheumatic arthritis prepared by crude drug.
Background technology
Rheumatic arthritis is one of main manifestations of rheumatic fever, belong to allergic disease, based on the morbidity of large joint, be very with joint of the lower extremity especially, account for 85% of sickness rate, secondly be the positions such as shoulder, elbow, local joint inflammation is obvious, and can occur together heating paresthesia simultaneously, as treated not in time, prolonged and repeatedly cause cardiorenal disease, threat to life.
Summary of the invention
The object of this invention is to provide a kind of take Chinese medicine as the medicine for the treatment of rheumatic arthritis prepared by crude drug, and this medicine is enriched blood yin nourishing, and blood circulation promoting and blood stasis dispelling, expelling wind and dampness, pain relieving are principle treatment, good to the therapeutic effect of rheumatic arthritis, have no side effect.
Medicine of the present invention is that crude drug prepares by the Chinese medicine of following parts by weight:
Radix Clematidis 2 ~ 4 Radix Angelicae Sinensis 10 ~ 20 Radix Cyathulae 7 ~ 14 Radix Angelicae Pubescentis 10 ~ 20
Rhizoma Et Radix Notopterygii 7 ~ 14 Rhizoma Corydalis 10 ~ 20 Radix Rehmanniae Preparata 10 ~ 20.
The medicine of above-mentioned each component can make said dosage form on any one pharmaceuticss such as powder, capsule, pill, and the preferred dosage form of the present invention is powder.
The concrete preparation method of drug powder of the present invention is: by said medicine by described parts by weight mix homogeneously, and be ground into 100 ~ 120 object medicated powder, sterilization obtains powder product.
The traditional Chinese medical science thinks that rheumatic arthritis mostly is outer and has wind-cold damp pathogen gas to invade human body in an opponent's defence, and inside have the heat-transformation of a specified duration of intrinsic heat wind and cold damp-stagnancy, passages through which vital energy circulates of being detained, obturation is obstructed to be formed.In prescription of the present invention, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, unit act like a bully monarch, yin nourishing of enriching blood, blood circulation promoting and blood stasis dispelling; Radix Angelicae Pubescentis, Radix Cyathulae are minister, expelling wind and dampness, dispersing cold for relieving pain; Radix Clematidis, Rhizoma Et Radix Notopterygii, diuretic, pain relieving.All medicines share and play yin nourishing of enriching blood, effect of blood circulation promoting and blood stasis dispelling, expelling wind and dampness, pain relieving, evident in efficacy to the treatment of rheumatic arthritis, with low cost.
For investigating the clinical efficacy of Drug therapy rheumatic arthritis of the present invention further, 55 routine rheumatoid arthritis patients are selected to carry out clinical observation on the therapeutic effect.
55 routine patients are all according to the diagnosis basis in " new Chinese medicine guideline of clinical investigations (first volume) ":
1, clinical manifestation: have streptococcal infection medical history; , can there be multiple and migrans joint aches acute stage, mostly occurs in large joint, can with redness pain or tuberosity or erythema; Chronic phase, only can feel joint aches;
2, laboratory examination: anti-" O " is at more than 1:500; Or erythrocyte sedimentation rate speeds; Or antistreptokinase is more than more than 80 units; Or antihyaluronidase is more than 128 units; Or C reflects protein positive;
3, X-ray film damages without sclerotin;
Be diagnosed as rheumatic arthritis.
Therapeutic Method
Adopt powder agent medicine of the present invention, 2 times on the one, each 25 grams.
Criterion of therapeutical effect
With reference to the criterion of therapeutical effect of " new Chinese medicine guideline of clinical investigations (first volume) ".Cure: after treatment, affected joints swells and ache disappearances, function of joint is improved or is recovered normally, and erythrocyte sedimentation rate, rheumatoid factor have recovered normal; Effective: affected joints swells and ache and is clearly better or disappears, erythrocyte sedimentation rate, rheumatoid factor titre reduce, or have recovered normal, but arthroncus not yet disappears; Effective: to treat rear affected joints pain or swell and ache and take a favorable turn; Invalid: to compare each side without progress with before treatment.
After all cases treatment, efficacy result is in table 1.
Efficacy result after the treatment of table 1 all cases.
| Number of cases | Cure n(%) | Effective n(%) | Effective n(%) | Invalid n(%) | Total effective rate n(%) |
| 55 | 23（41.8） | 20（36.4） | 6（10.9） | 6（10.9） | 49（89.1） |
Detailed description of the invention
Embodiment 1
Get Radix Clematidis 2 g, Radix Angelicae Sinensis 10 g, Radix Cyathulae 7 g, Radix Angelicae Pubescentis 10 g, Rhizoma Et Radix Notopterygii 7 g, Rhizoma Corydalis 10 g, Radix Rehmanniae Preparata 10 g mix homogeneously, be ground into 100 ~ 120 object medicated powder, sterilization obtains powder product.
Embodiment 2
Get Radix Clematidis 4g, Radix Angelicae Sinensis 20 g, Radix Cyathulae 14 g, Radix Angelicae Pubescentis 20 g, Rhizoma Et Radix Notopterygii 14 g, Rhizoma Corydalis 20 g, Radix Rehmanniae Preparata 20 g mix homogeneously, be ground into 100 ~ 120 object medicated powder, sterilization obtains powder product.
Claims (2)
1. treating a medicine for rheumatic arthritis, is that crude drug prepares by the Chinese medicine of following portions by weight:
Radix Clematidis 2 ~ 4 Radix Angelicae Sinensis 10 ~ 20 Radix Cyathulae 7 ~ 14 Radix Angelicae Pubescentis 10 ~ 20
Rhizoma Et Radix Notopterygii 7 ~ 14 Rhizoma Corydalis 10 ~ 20 Radix Rehmanniae Preparata 10 ~ 20.
2. the medicine for the treatment of rheumatic arthritis according to claim 1, is characterized in that described medicine to make powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410485218.0A CN104225056A (en) | 2014-09-22 | 2014-09-22 | Drug for treating rheumatic arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410485218.0A CN104225056A (en) | 2014-09-22 | 2014-09-22 | Drug for treating rheumatic arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104225056A true CN104225056A (en) | 2014-12-24 |
Family
ID=52214532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410485218.0A Pending CN104225056A (en) | 2014-09-22 | 2014-09-22 | Drug for treating rheumatic arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104225056A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435900A (en) * | 2015-01-06 | 2015-03-25 | 王国徽 | Medicine for treating rheumatic arthritis and preparation method |
-
2014
- 2014-09-22 CN CN201410485218.0A patent/CN104225056A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435900A (en) * | 2015-01-06 | 2015-03-25 | 王国徽 | Medicine for treating rheumatic arthritis and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614389B (en) | Traditional Chinese medicine patch | |
| CN102406766B (en) | Traditional Chinese medicine composition for treating bone fracture and application thereof | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN103479970B (en) | External medicine for treating rheumatic arthralgia | |
| CN104225056A (en) | Drug for treating rheumatic arthritis | |
| CN102078586A (en) | Medicament for treating cervical spondylosis | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN103948878B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN102920824B (en) | Liniment for treating bedsore and preparation method thereof | |
| CN101810831B (en) | Medicament for treating gynecological diseases | |
| CN101810668A (en) | Toxin drawing plaster | |
| CN104258326A (en) | Traditional Chinese medicine used for treating scapulohumeral periarthritis | |
| CN104027555A (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN102631435A (en) | Medicament for treating rheumatoid arthritis | |
| CN102727699A (en) | Externally used drug for treating rheumatic arthritis | |
| CN104107292A (en) | Traditional Chinese medicine preparation used for treating hyperosteogeny, and preparation method and application thereof | |
| CN103157011B (en) | Traditional Chinese medicine composite for promoting fracture healing | |
| CN101810709A (en) | Medicament for treating rheumatism | |
| CN102488864B (en) | Medicinal composition for treating herpes zoster | |
| CN106822271A (en) | It is a kind of to treat pharmaceutical composition of rheumatic Bi syndrome and its production and use | |
| CN106236899A (en) | A kind of Chinese medicine composition of anemofrigid-damp arthralgia | |
| CN102512523A (en) | Medicine for treating rheumatoid arthritis | |
| CN1823960A (en) | Traditional Chinese medicine for treating hemorrhoid | |
| CN104042703B (en) | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141224 |
|
| WD01 | Invention patent application deemed withdrawn after publication |